| Literature DB >> 25676513 |
Christopher Witte1, Vera Martos, Honor May Rose, Stefan Reinke, Stefan Klippel, Leif Schröder, Christian P R Hackenberger.
Abstract
The targeting of metabolically labeled glycans with conventional MRI contrast agents has proved elusive. In this work, which further expands the utility of xenon Hyper-CEST biosensors in cell experiments, we present the first successful molecular imaging of such glycans using MRI. Xenon Hyper-CEST biosensors are a novel class of MRI contrast agents with very high sensitivity. We designed a multimodal biosensor for both fluorescent and xenon MRI detection that is targeted to metabolically labeled sialic acid through bioorthogonal chemistry. Through the use of a state of the art live-cell bioreactor, it was demonstrated that xenon MRI biosensors can be used to image cell-surface glycans at nanomolar concentrations.Entities:
Keywords: bioorthogonal labeling; biosensors; glycosylation; host-guest systems; xenon
Mesh:
Substances:
Year: 2015 PMID: 25676513 DOI: 10.1002/anie.201410573
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336